Asselin; Magda

Patent Applications and Registrations

Patent applications and USPTO patent grants for Asselin; Magda.The latest application filed is for "benzofuranyl- and benzothienyl- piperazinyl quinolines and methods of their use".

Company Profile

0.12.14

Asselin; Magda - Mahwah NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists Grant 7,842,715 - Cole , et al. November 30, 2	2010-11-30
N-substituted-azacyclylamines as histamine-3 antagonists Grant 7,820,825 - Cole , et al. October 26, 2	2010-10-26
Substituted 3-cyanopyridines as protein kinase inhibitors Grant 7,781,591 - Cole , et al. August 24, 2	2010-08-24
Piperazine-piperidine antagonists and agonists of the 5-HT.sub.1A receptor Grant 7,671,056 - Asselin , et al. March 2, 2	2010-03-02
Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands Grant 7,671,079 - Cole , et al. March 2, 2	2010-03-02
Benzofuranyl- And Benzothienyl- Piperazinyl Quinolines And Methods Of Their Use App 20090054454 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-02-26
Antidepressant Piperidine Derivatives of Heterocycle-Fused Benzodioxans App 20090042895 - Webb; Michael Byron ; et al.	2009-02-12
Antidepressant piperidine derivatives of heterocyclefused benzodioxans Grant 7,479,500 - Webb , et al. January 20, 2	2009-01-20
Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands App 20080085925 - Cole; Derek Cecil ; et al.	2008-04-10
Substituted Cyanopyridines as protein kinase inhibitors App 20070287738 - Cole; Derek Cecil ; et al.	2007-12-13
Substituted 3-cyanopyridines as protein kinase inhibitors App 20070287708 - Cole; Derek Cecil ; et al.	2007-12-13
N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists App 20070270440 - Cole; Derek Cecil ; et al.	2007-11-22
Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands Grant 7,288,561 - Cole , et al. October 30, 2	2007-10-30
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use Grant 7,276,603 - Venkatesan , et al. October 2, 2	2007-10-02
N-substituted-azacyclylamines as histamine-3 antagonists App 20070219240 - Cole; Derek Cecil ; et al.	2007-09-20
Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors App 20070082880 - Boschelli; Diane H. ; et al.	2007-04-12
Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor App 20070027160 - Asselin; Magda ; et al.	2007-02-01
Antidepressant piperidine derivatives of heterocyclefused benzodioxans App 20050228009 - Webb, Michael Byron ; et al.	2005-10-13
Antidepressant piperidine derivatives of heterocycle-fused benzodioxans Grant 6,939,877 - Webb , et al. September 6, 2	2005-09-06
Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-Hydroxytryptamine-6 ligands App 20050101596 - Cole, Derek Cecil ; et al.	2005-05-12
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use App 20050059673 - Venkatesan, Aranapakam Mudumbai ; et al.	2005-03-17
Antidepressant piperidine derivatives of heterocycle-fused benzodioxans App 20040147523 - Webb, Michael Byron ; et al.	2004-07-29
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression App 20020045628 - Mewshaw, Richard E. ; et al.	2002-04-18
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression Grant 6,313,126 - Mewshaw , et al. November 6, 2	2001-11-06
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders Grant 6,245,799 - Asselin , et al. June 12, 2	2001-06-12
Pyrazolopyrimidine-2,4-dione sulfonamides Grant 6,133,273 - Gilbert , et al. October 17, 2	2000-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.